Logo image of LON.MI

LONGINO & CARDENAL - SPA (LON.MI) Stock Fundamental Analysis

BIT:LON - Euronext Milan - IT0005337073 - Common Stock - Currency: EUR

1.36  -0.01 (-0.73%)

Fundamental Rating

3

Overall LON gets a fundamental rating of 3 out of 10. We evaluated LON against 53 industry peers in the Hotels, Restaurants & Leisure industry. LON has a bad profitability rating. Also its financial health evaluation is rather negative. LON has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LON had negative earnings in the past year.
LON had a positive operating cash flow in the past year.
LON had negative earnings in 4 of the past 5 years.
LON had negative operating cash flow in 4 of the past 5 years.
LON.MI Yearly Net Income VS EBIT VS OCF VS FCFLON.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -0.73%, LON is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
LON has a Return On Equity of -3.35%. This is comparable to the rest of the industry: LON outperforms 46.30% of its industry peers.
LON has a Return On Invested Capital (4.28%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.73%
ROE -3.35%
ROIC 4.28%
ROA(3y)-4.69%
ROA(5y)-3.48%
ROE(3y)-17.5%
ROE(5y)-13.14%
ROIC(3y)N/A
ROIC(5y)N/A
LON.MI Yearly ROA, ROE, ROICLON.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80 100

1.3 Margins

Looking at the Operating Margin, with a value of 1.33%, LON is doing worse than 64.81% of the companies in the same industry.
LON's Operating Margin has declined in the last couple of years.
LON's Gross Margin of 17.13% is on the low side compared to the rest of the industry. LON is outperformed by 72.22% of its industry peers.
In the last couple of years the Gross Margin of LON has remained more or less at the same level.
Industry RankSector Rank
OM 1.33%
PM (TTM) N/A
GM 17.13%
OM growth 3YN/A
OM growth 5Y-43.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.83%
GM growth 5Y1%
LON.MI Yearly Profit, Operating, Gross MarginsLON.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LON is destroying value.
The number of shares outstanding for LON remains at a similar level compared to 1 year ago.
Compared to 5 years ago, LON has about the same amount of shares outstanding.
LON has a worse debt/assets ratio than last year.
LON.MI Yearly Shares OutstandingLON.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
LON.MI Yearly Total Debt VS Total AssetsLON.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 2.43 indicates that LON is not a great score, but indicates only limited risk for bankruptcy at the moment.
LON has a better Altman-Z score (2.43) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.79 indicates that LON is somewhat dependend on debt financing.
LON has a Debt to Equity ratio (0.79) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 2.43
ROIC/WACC0.68
WACC6.29%
LON.MI Yearly LT Debt VS Equity VS FCFLON.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

2.3 Liquidity

LON has a Current Ratio of 1.29. This is a normal value and indicates that LON is financially healthy and should not expect problems in meeting its short term obligations.
LON's Current ratio of 1.29 is fine compared to the rest of the industry. LON outperforms 75.93% of its industry peers.
LON has a Quick Ratio of 1.03. This is a normal value and indicates that LON is financially healthy and should not expect problems in meeting its short term obligations.
LON has a Quick ratio of 1.03. This is comparable to the rest of the industry: LON outperforms 57.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.03
LON.MI Yearly Current Assets VS Current LiabilitesLON.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

LON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.81%, which is quite impressive.
The Revenue has grown by 12.81% in the past year. This is quite good.
The Revenue has been growing slightly by 2.23% on average over the past years.
EPS 1Y (TTM)57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.49%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y22.18%
Revenue growth 5Y2.23%
Sales Q2Q%3.6%

3.2 Future

The Earnings Per Share is expected to grow by 64.03% on average over the next years. This is a very strong growth
LON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.39% yearly.
EPS Next Y127.27%
EPS Next 2Y104.49%
EPS Next 3Y88.78%
EPS Next 5Y64.03%
Revenue Next Year3.33%
Revenue Next 2Y6.71%
Revenue Next 3Y7.94%
Revenue Next 5Y11.39%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LON.MI Yearly Revenue VS EstimatesLON.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
LON.MI Yearly EPS VS EstimatesLON.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LON. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 11.22, which indicates a very decent valuation of LON.
LON's Price/Forward Earnings ratio is rather cheap when compared to the industry. LON is cheaper than 85.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LON to the average of the S&P500 Index (21.27), we can say LON is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.22
LON.MI Price Earnings VS Forward Price EarningsLON.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LON is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.44
LON.MI Per share dataLON.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

LON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LON's earnings are expected to grow with 88.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y104.49%
EPS Next 3Y88.78%

More info and screens

0

5. Dividend

5.1 Amount

LON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LONGINO & CARDENAL - SPA

BIT:LON (5/2/2025, 7:00:00 PM)

1.36

-0.01 (-0.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.50M
Analysts80
Price Target3.32 (144.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.64%
PT rev (3m)-14.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-57.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.71%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.22
P/S 0.23
P/FCF N/A
P/OCF 24.82
P/B 1.96
P/tB 2.51
EV/EBITDA 13.44
EPS(TTM)-0.02
EYN/A
EPS(NY)0.12
Fwd EY8.91%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.05
OCFY4.03%
SpS5.93
BVpS0.7
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.73%
ROE -3.35%
ROCE 5.71%
ROIC 4.28%
ROICexc 4.97%
ROICexgc 5.71%
OM 1.33%
PM (TTM) N/A
GM 17.13%
FCFM N/A
ROA(3y)-4.69%
ROA(5y)-3.48%
ROE(3y)-17.5%
ROE(5y)-13.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-48.71%
ROICexc growth 3YN/A
ROICexc growth 5Y-48.07%
OM growth 3YN/A
OM growth 5Y-43.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.83%
GM growth 5Y1%
F-Score6
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA 3.02
Cap/Depr 102.19%
Cap/Sales 1.79%
Interest Coverage 250
Cash Conversion 29.97%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.03
Altman-Z 2.43
F-Score6
WACC6.29%
ROIC/WACC0.68
Cap/Depr(3y)216.35%
Cap/Depr(5y)195.6%
Cap/Sales(3y)4.69%
Cap/Sales(5y)3.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.49%
EPS Next Y127.27%
EPS Next 2Y104.49%
EPS Next 3Y88.78%
EPS Next 5Y64.03%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y22.18%
Revenue growth 5Y2.23%
Sales Q2Q%3.6%
Revenue Next Year3.33%
Revenue Next 2Y6.71%
Revenue Next 3Y7.94%
Revenue Next 5Y11.39%
EBIT growth 1Y107.98%
EBIT growth 3YN/A
EBIT growth 5Y-41.76%
EBIT Next Year934.45%
EBIT Next 3Y195.72%
EBIT Next 5Y150.52%
FCF growth 1Y93.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.04%
OCF growth 3YN/A
OCF growth 5YN/A